+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Parenteral Nutrition Market Size, Share & Trends Analysis Report by Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion), Stage Type, Indication, Sales Channel, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 125 Pages
  • June 2024
  • Region: Global
  • Grand View Research
  • ID: 4761233
Parenteral Nutrition Market Growth & Trends
The global parenteral nutrition market size is expected to reach USD 10.68 billion by 2030, registering a CAGR of 6.01% from 2024 to 2030. Increasing prevalence of malnutrition, rising metabolic disorders, growing geriatric population, and advancement in healthcare infrastructure are some of the factors driving the market growth. The rising geriatric population has significantly contributed to the increasing demand for parenteral nutrition (PN) as the elderly population is more vulnerable to several diseases. For instance, according to the Population Reference Bureau (PRB), the population of the U.S. aged above 65 years is expected to increase from 58 million in 2022 to 82 million in 2050.

The presence of a large pool of geriatric population with low immunity levels and susceptibility to neurological diseases, cardiovascular disorders, cancer, and spinal injuries is a high-impact rendering driver of the market. Moreover, a surge in essential nutrition deficiency among critically ill patients; and growing awareness about hospital-related malnutrition are a few key factors increasing PN adoption. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth. However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. The growing population worldwide has increased healthcare costs and household food expenditures.

Hence, a higher birth rate is expected to impact nutrition levels, thereby driving market growth. According to the United Nations statistics, the world population is expected to increase from 8 billion in 2022 to 9.7 billion in 2050 and 10.4 billion by the mid-2080s. This rising population can increase the scarcity of nutritional ingredients, fueling market growth. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and the trend is anticipated to continue over the forecast period. In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) was 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide.

key Request a free sample copy or view report summary: Parenteral Nutrition Market Report

Parenteral Nutrition Market Report Highlights

Based on nutrient type, the market is segmented into carbohydrates, parenteral lipid emulsions, single-dose amino acid solution, trace elements, and vitamins & minerals. The single-dose amino acid segment held the largest revenue share of 30.7% in 2023 owing to its compatibility with all age groups and its lesser adverse effects compared to other types of parenteral nutrition

Based on stage, the adult segment dominated the market with a revenue share of 87.1% in 2023 owing to the vulnerability of the elderly population to various chronic conditions such as cancer, diabetes, and Alzheimer's disease

Institutional sales channel dominated the market with the largest revenue share of 48.1% in 2023. On the other hand, online channels are anticipated to exhibit the fastest growth rate over the forecast period

In 2023, North America held the largest revenue share of 41.5%, while Asia Pacific is expected to witness the fastest growth due to rising healthcare expenditure, improving healthcare infrastructure, growing per capita income, and high occurrence of preterm births

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Details of primary research
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Nutrition Type Outlook
2.2.2. Stage Type Outlook
2.2.3. Indication Outlook
2.2.4. Sales Channel Outlook
2.3. Competitive Insights
Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Industry Analysis
3.2.1. User Perspective Analysis
3.2.2. Key End-users
3.3. Technology Outlook
3.4. Regulatory Framework
3.5. Market Dynamics
3.5.1. Market Drivers Analysis
3.5.1.1. Rising geriatric population
3.5.1.2. Increasing natality rate
3.5.1.3. Increasing incidence of cancer
3.5.1.4. Growing number of premature births
3.5.1.5. Increasing risk of malnutrition
3.5.2. Market Restraints Analysis
3.5.2.1. Shortage of parenteral nutrition products
3.5.2.2. High risk of infections
3.5.3. Industry Challenges and Opportunity Analysis
3.6. Parenteral Nutrition Market Analysis Tools
3.6.1. Porter’s Analysis
3.6.1.1. Bargaining power of the suppliers
3.6.1.2. Bargaining power of the buyers
3.6.1.3. Threats of substitution
3.6.1.4. Threats from new entrants
3.6.1.5. Competitive rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political landscape
3.6.2.2. Economic and Social landscape
3.6.2.3. Technological landscape
3.6.2.4. Environmental landscape
3.6.2.5. Legal landscape
3.7. Major Deals & Strategic Alliances Analysis in the Parenteral Nutrition Industry
3.8. Impact of COVID-19
Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Nutrient Type Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. Parenteral Nutrition Market: By Nutrient Type, 2018 to 2030
4.5. Carbohydrates
4.5.1. Carbohydrates Market Revenue Estimates and Forecasts, 2018-2030
4.6. Parenteral Lipid Emulsion
4.6.1. Parenteral Lipid Emulsion Market Revenue Estimates and Forecasts, 2018-2030
4.7. Single Dose Amino Acid Solution
4.7.1. Single Dose Amino Acid Solution Market Revenue Estimates and Forecasts, 2018-2030
4.8. Trace Elements
4.8.1. Trace Elements Market Revenue Estimates and Forecasts, 2018-2030
4.9. Vitamins & Minerals
4.9.1. Vitamins & Minerals Market Revenue Estimates and Forecasts, 2018-2030
Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Stage Type Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. Parenteral Nutrition Market: By Stage Type, 2018 to 2030
5.5. Adult
5.5.1. Adult Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.6. Pediatric
5.6.1. Pediatric Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis
6.1. Definition and Scope
6.2. Indication Market Share Analysis, 2023 & 2030
6.3. Segment Dashboard
6.4. Parenteral Nutrition Market: By Indication, 2018 to 2030
6.5. Pediatrics Alzheimer’s
6.5.1. Alzheimer’s Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.6. Nutrition Deficiency
6.6.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.7. Cancer Care
6.7.1. Cancer Care Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.8. Diabetes
6.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.9. Chronic Kidney Disease
6.9.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.10. Orphan Diseases
6.10.1. Orphan Diseases Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.11. Dysphagia
6.11.1. Dysphagia Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.12. Pain Management
6.12.1. Pain Management Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.13. Malabsorption/GI.Disorder/Diarrhea
6.13.1. Malabsorption/GI.Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.14. Others
6.14.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis
7.1. Definition and Scope
7.2. Sales Channel Market Share Analysis, 2023 & 2030
7.3. Segment Dashboard
7.4. Parenteral Nutrition Market: By Sales Channel, 2018 to 2030
7.5. Online
7.5.1. Online Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.6. Retail
7.6.1. Retail Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
7.7. Institutional
7.7.1. Institutional Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis by Country, Nutrient Type, Stage Type, Indication and Sales Channel
8.1. Definition and Scope
8.2. Regional Market Share Analysis, 2023 & 2030
8.3. Regional Market Dashboard
8.4. Regional Market Snapshot
8.5. SWOT Analysis
8.5.1. North America
8.5.2. Europe
8.5.3. Asia Pacific
8.5.4. Latin America
8.5.5. Middle East & Africa
8.6. Parenteral Nutrition Market Share, By Region, 2023 & 2030 (USD Billion)
8.7. North America
8.7.1. North America Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.7.2. U.S.
8.7.2.1. Key Country Dynamics
8.7.2.2. Regulatory Landscape/Reimbursement Scenario
8.7.2.3. Competitive Insights
8.7.2.4. U.S. Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.7.3. Canada
8.7.3.1. Key Country Dynamics
8.7.3.2. Regulatory Landscape/Reimbursement Scenario
8.7.3.3. Competitive Insights
8.7.3.4. Canada Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.8. Europe
8.8.1. Europe Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.8.2. UK
8.8.2.1. Key Country Dynamics
8.8.2.2. Regulatory Landscape/Reimbursement Scenario
8.8.2.3. Competitive Insights
8.8.2.4. UK Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.8.3. Germany
8.8.3.1. Key Country Dynamics
8.8.3.2. Regulatory Landscape/Reimbursement Scenario
8.8.3.3. Competitive Insights
8.8.3.4. Germany Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.8.4. France
8.8.4.1. Key Country Dynamics
8.8.4.2. Regulatory Landscape/Reimbursement Scenario
8.8.4.3. Competitive Insights
8.8.4.4. France Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.8.5. Italy
8.8.5.1. Key Country Dynamics
8.8.5.2. Regulatory Landscape/Reimbursement Scenario
8.8.5.3. Competitive Insights
8.8.5.4. Italy Parenteral Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.8.6. Spain
8.8.6.1. Key Country Dynamics
8.8.6.2. Regulatory Landscape/Reimbursement Scenario
8.8.6.3. Competitive Insights
8.8.6.4. Spain Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.8.7. Sweden
8.8.7.1. Key Country Dynamics
8.8.7.2. Regulatory Landscape/Reimbursement Scenario
8.8.7.3. Competitive Insights
8.8.7.4. Sweden Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.8.8. Denmark
8.8.8.1. Key Country Dynamics
8.8.8.2. Regulatory Landscape/Reimbursement Scenario
8.8.8.3. Competitive Insights
8.8.8.4. Denmark Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.8.9. Norway
8.8.9.1. Key Country Dynamics
8.8.9.2. Regulatory Landscape/Reimbursement Scenario
8.8.9.3. Competitive Insights
8.8.9.4. Norway Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.9. Asia Pacific
8.9.1. Asia Pacific Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.9.2. China
8.9.2.1. Key Country Dynamics
8.9.2.2. Regulatory Landscape/Reimbursement Scenario
8.9.2.3. Competitive Insights
8.9.2.4. China Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.9.3. Japan
8.9.3.1. Key Country Dynamics
8.9.3.2. Regulatory Landscape/Reimbursement Scenario
8.9.3.3. Competitive Insights
8.9.3.4. Japan Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.9.4. India
8.9.4.1. Key Country Dynamics
8.9.4.2. Regulatory Landscape/Reimbursement Scenario
8.9.4.3. Competitive Insights
8.9.4.4. India Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.9.5. South Korea
8.9.5.1. Key Country Dynamics
8.9.5.2. Regulatory Landscape/Reimbursement Scenario
8.9.5.3. Competitive Insights
8.9.5.4. South Korea Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.9.6. Australia
8.9.6.1. Key Country Dynamics
8.9.6.2. Regulatory Landscape/Reimbursement Scenario
8.9.6.3. Competitive Insights
8.9.6.4. Australia Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.9.7. Thailand
8.9.7.1. Key Country Dynamics
8.9.7.2. Regulatory Landscape/Reimbursement Scenario
8.9.7.3. Competitive Insights
8.9.7.4. Thailand Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.10. Latin America
8.10.1. Latin America Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.10.2. Brazil
8.10.2.1. Key Country Dynamics
8.10.2.2. Regulatory Landscape/Reimbursement Scenario
8.10.2.3. Competitive Insights
8.10.2.4. Brazil Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.10.3. Mexico
8.10.3.1. Key Country Dynamics
8.10.3.2. Regulatory Landscape/Reimbursement Scenario
8.10.3.3. Competitive Insights
8.10.3.4. Mexico Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.10.4. Argentina
8.10.4.1. Key Country Dynamics
8.10.4.2. Regulatory Landscape/Reimbursement Scenario
8.10.4.3. Competitive Insights
8.10.4.4. Argentina Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.11. Middle East and Africa
8.11.1. Middle East and Africa Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.11.2. Saudi Arabia
8.11.2.1. Key Country Dynamics
8.11.2.2. Regulatory Landscape/Reimbursement Scenario
8.11.2.3. Competitive Insights
8.11.2.4. Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.11.3. UAE
8.11.3.1. Key Country Dynamics
8.11.3.2. Regulatory Landscape/Reimbursement Scenario
8.11.3.3. Competitive Insights
8.11.3.4. UAE Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.11.4. South Africa
8.11.4.1. Key Country Dynamics
8.11.4.2. Regulatory Landscape/Reimbursement Scenario
8.11.4.3. Competitive Insights
8.11.4.4. South Africa Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
8.11.5. Kuwait
8.11.5.1. Key Country Dynamics
8.11.5.2. Regulatory Landscape/Reimbursement Scenario
8.11.5.3. Competitive Insights
8.11.5.4. Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Market Share Analysis
9.4. Company Heat Map Analysis
9.5. Strategy Mapping
9.5.1. Expansion
9.5.2. Mergers & Acquisition
9.5.3. Partnerships & Collaborations
9.5.4. New Product Launches
9.5.5. Research And Development
9.6. Company Profiles
9.6.1. Baxter
9.6.1.1. Company Overview
9.6.1.2. Financial Performance
9.6.1.3. Product Benchmarking
9.6.1.4. Strategic initiatives
9.6.2. Allergan
9.6.2.1. Company Overview
9.6.2.2. Financial Performance
9.6.2.3. Product Benchmarking
9.6.2.4. Strategic initiatives
9.6.3. Actavis Inc.
9.6.3.1. Company Overview
9.6.3.2. Financial Performance
9.6.3.3. Product Benchmarking
9.6.3.4. Strategic initiatives
9.6.4. Otsuka Pharmaceutical Factory, Inc.
9.6.4.1. Company Overview
9.6.4.2. Financial Performance
9.6.4.3. Product Benchmarking
9.6.4.4. Strategic initiatives
9.6.5. Grifols, S.A.
9.6.5.1. Company Overview
9.6.5.2. Financial Performance
9.6.5.3. Product Benchmarking
9.6.5.4. Strategic initiatives
9.6.6. B. Braun Melsungen AG
9.6.6.1. Company Overview
9.6.6.2. Financial Performance
9.6.6.3. Product Benchmarking
9.6.6.4. Strategic initiatives
9.6.7. Vifor Pharma
9.6.7.1. Company Overview
9.6.7.2. Financial Performance
9.6.7.3. Product Benchmarking
9.6.7.4. Strategic initiatives
9.6.8. Fresenius Kabi AG
9.6.8.1. Company Overview
9.6.8.2. Financial Performance
9.6.8.3. Product Benchmarking
9.6.8.4. Strategic initiatives
9.6.9. Sichuan Kelun Pharmaceutical Co., Ltd
9.6.9.1. Company Overview
9.6.9.2. Financial Performance
9.6.9.3. Product Benchmarking
9.6.9.4. Strategic initiatives
9.6.10. Pfizer Inc. (Hospira Inc.)
9.6.10.1. Company Overview
9.6.10.2. Financial Performance
9.6.10.3. Product Benchmarking
9.6.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 4 North America Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 5 North America Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 6 North America Parenteral nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Billion)
Table 7 U.S. Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 8 U.S. Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 9 U.S. Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 10 U.S. Parenteral nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Billion)
Table 11 Canada Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 12 Canada Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 13 Canada Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 14 Canada Parenteral nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Billion)
Table 15 Europe Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 16 Europe Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 17 Europe Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 18 Europe Parenteral nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Billion)
Table 19 UK Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 20 UK Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 21 UK Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 22 UK Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 23 Germany Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 24 Germany Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 25 Germany Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 26 Germany Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 27 France Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 28 France Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 29 France Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 30 France Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 31 Italy Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 32 Italy Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 33 Italy Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 34 Italy Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 35 Spain Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 36 Spain Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 37 Spain Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 38 Spain Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 39 Sweden Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 40 Sweden Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 41 Sweden Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 42 Sweden Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 43 Denmark Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 44 Denmark Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 45 Denmark Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 46 Denmark Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 47 Norway Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 48 Norway Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 49 Norway Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 50 Norway Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 51 Asia Pacific Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 52 Asia Pacific Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 53 Asia Pacific Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 54 Asia Pacific Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 55 Japan Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 56 Japan Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 57 Japan Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 58 Japan Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 59 China Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 60 China Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 61 China Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 62 China Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 63 India Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 64 India Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 65 India Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 66 India Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 67 Australia Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 68 Australia Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 69 Australia Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 70 Australia Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 71 South Korea Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 72 South Korea Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 73 South Africa Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 74 South Korea Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 75 Thailand Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 76 Thailand Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 77 Thailand Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 78 Thailand Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 79 Latin America Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 80 Latin America Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 81 Latin America Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 82 Latin America Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 83 Brazil Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 84 Brazil Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 85 Brazil Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 86 Brazil Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 87 Mexico Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 88 Mexico Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 89 Mexico Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 90 Mexico Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 91 Argentina Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 92 Argentina Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 93 Argentina Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 94 Argentina Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 95 MEA Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 96 MEA Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 97 MEA Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 98 MEA Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 99 South Africa Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 100 South Africa Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 101 South Africa Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 102 South Africa Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 103 Saudi Arabia Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 104 Saudi Arabia Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 105 Saudi Arabia Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 106 Saudi Arabia Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 107 UAE Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 108 UAE Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 109 UAE Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 110 UAE Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
Table 111 Kuwait Parenteral nutrition market estimates and forecasts, by nutrient type, 2018-2030 (USD Billion)
Table 112 Kuwait Parenteral nutrition market estimates and forecasts, by stage type, 2018-2030 (USD Billion)
Table 113 Kuwait Parenteral nutrition market estimates and forecasts, by indication, 2018-2030 (USD Billion)
Table 114 Kuwait Parenteral nutrition market estimates and forecasts, by sales channel, 2018-2030 (USD Billion)
List of Figures
Figure 1 Parenteral Nutrition Market Segmentation
Figure 2 Information Procurement
Figure 3 Data Analysis Models
Figure 4 Market Formulation and Validation
Figure 5 Data Validating & Publishing
Figure 6 Market Snapshot
Figure 7 Segment Snapshot (1/2)
Figure 8 Segment Snapshot (2/2)
Figure 9 Competitive Landscape Snapshot
Figure 10 Parenteral Nutrition- Market Size and Growth Prospects (USD Billion)
Figure 11 Parenteral Nutrition Market: Industry Value Chain Analysis
Figure 12 Parenteral Nutrition Market: Market Dynamics
Figure 13 Parenteral Nutrition Market: PORTER’s Analysis
Figure 14 Parenteral Nutrition Market: PESTEL Analysis
Figure 15 Parenteral Nutrition Market Share by Nutrient Type 2023 & 2030 (USD Billion)
Figure 16 Parenteral Nutrition Market, by Nutrient Type: Market Share, 2023 & 2030
Figure 17 Carbohydrates Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 18 Parenteral Lipid Emulsion Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 19 Single Dose Amino Acid Solution Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 20 Trace Elements Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 21 Vitamins & Minerals Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 22 Parenteral Nutrition Market, by Stage Type: Key Takeaways
Figure 23 Parenteral Nutrition Market, by Stage Type: Market Share, 2023 & 2030
Figure 24 Adult Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 25 Pediatric Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 26 Parenteral Nutrition Market Share by Indication 2023 & 2030 (USD Billion)
Figure 27 Parenteral Nutrition Market, by Indication: Market Share, 2023 & 2030
Figure 28 Pediatric's Alzaimers Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 29 Nutrition Deficiency Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 30 Cancer Care Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 31 Diabetes Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 32 Chronic Kidney Disease Market Estimates & Forecasts, 2018-2030 (USD Million
Figure 33 Orphan Disease Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 34 Dysphagia Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 35 Pain Management Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 36 Malabsorption/GI.Disorder/Diarrhea Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 37 Others Market Estimates & Forecasts, 2018-2030 (USD Million)
Figure 38 Parenteral Nutrition Market, by Sales Channel: Key Takeaways
Figure 39 Parenteral Nutrition Market, by Sales Channel: Market Share, 2023 & 2030
Figure 40 Online Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 41 Retail Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 42 Institutional Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 43 Parenteral Nutrition Market Revenue, by Region, 2023 & 2030 (USD Billion)
Figure 44 Regional Marketplace: Key Takeaways
Figure 45 Regional Marketplace: Key Takeaways
Figure 46 North America Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 47 U.S. Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 48 Canada Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 49 Europe Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 50 UK Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 51 Germany Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 52 France Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 53 ItalyParenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 54 Spain Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 55 Denmark Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 56 Sweden Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 57 Norway Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 58 Asia Pacific Parenteral Nutrition Market Estimates and Forecast, 2018-2030 (USD Billion)
Figure 59 China Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 60 Japan Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 61 India Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 62 South Korea Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 63 Thailand Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 64 Australia Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 65 Latin America Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 66 Brazil Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 67 Mexico Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 68 Argentina Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 69 MEA Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 70 Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 71 UAE Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 72 South Africa Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 73 Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 74 Key Company Categorization
Figure 75 Company Market Positioning
Figure 76 Key Company Market Share Analysis, 2023
Figure 77 Strategic Framework

Companies Mentioned

  • Baxter
  • Allergan
  • Actavis Inc.
  • Otsuka Pharmaceutical Factory, Inc.
  • Grifols, S.A.
  • Braun Melsungen AG
  • Vifor Pharma
  • Fresenius Kabi AG
  • Sichuan Kelun Pharmaceutical Co., Ltd
  • Pfizer Inc. (Hospira Inc.)

Methodology

Loading
LOADING...

Table Information